◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Cyfuse Biomedical K.K. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022
+Revenue 54.4M 61.1M 374.5M
Revenue Growth % -10.9% -83.7% --
+Operating Income -896.1M -697.4M -425.1M
Operating Margin % -1645.9% -1141.2% -113.5%
Non Operating Income 46.9M 131.8M 47.6M
Non Operating Expenses 20.5M 20.6M 55.7M
Ordinary Income -869.7M -586.2M -433.2M
Income Before Taxes -869.7M -586.2M -472.0M
Income Taxes 2.5M 3.0M 2.0M
+Net Income -872.2M -589.2M -474.0M
Net Margin % -1602.0% -964.1% -126.6%
Eps -108.34 -75.42 -177.67
Depreciation Amortization 36.0M 38.1M 54.3M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022
Cash And Deposits 3.1B 3.9B 4.4B
Current Assets 3.2B 4.0B 4.6B
Property Plant Equipment 141.8M 170.0M 189.0M
Noncurrent Assets 277.9M 227.4M 250.0M
Total Assets 3.5B 4.2B 4.8B
Current Liabilities 648.6M 666.3M 682.5M
Total Liabilities 975.6M 1.0B 1.0B
Retained Earnings -2.9B -2.0B -1.4B
Total Equity 2.5B 3.2B 3.8B
Equity Ratio 0.71 0.76 0.78
Book Value Per Share 304.60 405.71 484.88
Num Employees 21.00 21.00 21.00
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022
Operating Cash Flow -760.6M -562.3M -403.6M
Investing Cash Flow -8.6M -19.5M -430.7M
Financing Cash Flow -52.0M 18.2M 2.7B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...